The effects of LDL-cholesterol and activation of CD36/oxidised LDL receptor warrant further investigation, as it has been shown that CD36 mediates multiple pathways associated with the early pathogenesis and progression of diabetes-related complications in general [44]. This evidence concerns the gene CD36 and diabetes mellitus.